Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2020-2024

Global Amniotic Membrane Market

About this market

Technavio’s amniotic membrane market analysis considers sales from cryopreserved amniotic membrane and dehydrated amniotic membrane types. Our study also finds the sales of amniotic membrane in Asia, Europe, North America, and ROW. In 2019, the cryopreserved amniotic membrane segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increased coverage of cryopreserved products in reimbursement schemes of governments will play a significant role in the cryopreserved amniotic membrane segment to maintain its market position. Also, our global amniotic membrane market report looks at factors such as extensive use of amniotic membrane transplantation in ophthalmic surgeries, high demand for amniotic membrane in wound repair and reconstruction, and rising demand for biocompatible scaffolds. However, a limited supply of amniotic membranes, the presence of stringent regulations, and issues related to preservations and contamination may hamper the growth of the amniotic membrane industry over the forecast period.

Global Amniotic Membrane Market

Overview

Rising demand for biocompatible scaffolds

Amniotic membranes have become essential components in tissue engineering-based research and treatment procedures that incorporate the use of these biocompatible membranes as a scaffold. The increasing demand for naturally derived materials in tissue scaffolding has helped surge the demand for amniotic membranes. These membranes have a specialized structure and show substantial biological viability (low immunogenicity, anti-inflammatory, anti-fibrosis, and reasonable mechanical property) that makes them an ideal candidate for creating bio-scaffolds. The increasing demand for bio-scaffolds in repair and regenerative therapies for the treatment of bone, cartilage, ligament, skin, vascular tissues, neural tissues, and skeletal muscles will lead to the expansion of the global amniotic membrane market at a CAGR of over 13% during the forecast period.

Rise in the development of new applications through research

Intense growth in government funding and research activities in the global amniotic membrane market has resulted in the development of potential applications for amniotic membranes that are expected to find significant adoption in the coming years. For instance, amniotic membrane-based therapies have become an integral part of regenerative medicines. Moreover, advances in tissue preservations have resulted in the pipeline development of amniotic membranes with new preservation technologies such as viable lyopreserved human amniotic membrane (VLAM) that claims improved benefits in diabetic wound treatments and longer shelf life. Other potential developments under research include the use of amniotic membranes in tissue remodeling (denuded amniotic membrane), anti-cancer therapy, and lower nasal reconstruction. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global amniotic membrane market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of several major players, the global amniotic membrane market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane manufacturers, that include Celularity Inc., Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc.

Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Vendor offerings
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ millions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
    • Market Outlook
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market segmentation by type
    • Table Type - Market share 2019-2024 (%)
    • Comparison by type
      • Table Comparison by type
    • Cryopreserved amniotic membrane - Market size and forecast 2019-2024
      • Table Cryopreserved amniotic membrane - Market size and forecast 2019-2024 ($ millions)
      • Table Cryopreserved amniotic membrane - Year-over-year growth 2020-2024 (%)
    • Dehydrated amniotic membrane - Market size and forecast 2019-2024
      • Table Dehydrated amniotic membrane - Market size and forecast 2019-2024 ($ millions)
      • Table Dehydrated amniotic membrane - Year-over-year growth 2020-2024 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ millions)
      • Table North America - Year-over-year growth 2020-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ millions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ millions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ millions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • Growing reimbursement coverage for new products
    • Rise in development of new applications through research
    • Industry consolidation through mergers and acquisitions
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Celularity Inc.
      • Table Celularity Inc. - Vendor overview
      • Table Celularity Inc. - Business segments
      • Table Celularity Inc. - Organizational developments
      • Table Celularity Inc. - Key customers
    • Human Regenerative Technologies LLC
      • Table Human Regenerative Technologies LLC - Vendor overview
      • Table Human Regenerative Technologies LLC - Product segments
      • Table Human Regenerative Technologies LLC - Key offerings
    • Integra LifeSciences Holdings Corp.
      • Table Integra LifeSciences Holdings Corp. - Vendor overview
      • Table Integra LifeSciences Holdings Corp. - Business segments
      • Table Integra LifeSciences Holdings Corp. - Organizational developments
      • Table Integra LifeSciences Holdings Corp. - Geographic focus
      • Table Integra LifeSciences Holdings Corp. - Segment focus
      • Table Integra LifeSciences Holdings Corp. - Key offerings
    • Katena Products Inc.
      • Table Katena Products Inc. - Vendor overview
      • Table Katena Products Inc. - Product segments
      • Table Katena Products Inc. - Organizational developments
      • Table Katena Products Inc. - Key offerings
    • MiMedx Group Inc.
      • Table MiMedx Group Inc. - Vendor overview
      • Table MiMedx Group Inc. - Business segments
      • Table MiMedx Group Inc. - Organizational developments
      • Table MiMedx Group Inc. - Key offerings
    • NuVision Biotherapies Ltd.
      • Table NuVision Biotherapies Ltd. - Vendor overview
      • Table NuVision Biotherapies Ltd. - Business segments
      • Table NuVision Biotherapies Ltd. - Organizational developments
      • Table NuVision Biotherapies Ltd. - Key offerings
    • Orthofix Medical Inc.
      • Table Orthofix Medical Inc. - Vendor overview
      • Table Orthofix Medical Inc. - Business segments
      • Table Orthofix Medical Inc. - Organizational developments
      • Table Orthofix Medical Inc. - Geographic focus
      • Table Orthofix Medical Inc. - Segment focus
      • Table Orthofix Medical Inc. - Key offerings
    • Stryker Corp.
      • Table Stryker Corp. - Vendor overview
      • Table Stryker Corp. - Business segments
      • Table Stryker Corp. - Organizational developments
      • Table Stryker Corp. - Geographic focus
      • Table Stryker Corp. - Segment focus
      • Table Stryker Corp. - Key offerings
    • Surgenex LLC
      • Table Surgenex LLC - Vendor overview
      • Table Surgenex LLC - Product segments
      • Table Surgenex LLC - Key offerings
    • TissueTech Inc.
      • Table TissueTech Inc. - Vendor overview
      • Table TissueTech Inc. - Business segments
      • Table TissueTech Inc. - Organizational developments
      • Table TissueTech Inc. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook